Clinical Trials Browser

Phase 3 × miraculin protein, Synsepalum dulcificum × Clear all

NCT05273307 2025-09-22

Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation Therapy

Phase 3 Recruiting

Head and Neck Neoplasms, Taste Disorders